1-8 of 8
Authors: Francesco De Leonardis
Sort by
Journal Article
P115 Long-term efficacy of filgotinib monotherapy and combination therapy: interim results from a post hoc analysis of the FINCH 4 study
Maya Buch and others
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.155, https://doi.org/10.1093/rheumatology/keaf142.155
Published: 28 April 2025
Journal Article
P117 Efficacy of filgotinib in patients with rheumatoid arthritis: Week 156 results from a long-term extension study
Maya H Buch and others
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.158, https://doi.org/10.1093/rheumatology/keae163.158
Published: 24 April 2024
Journal Article
075 Summary of findings from the Burden of Rheumatoid Arthritis across Europe Socioeconomic Survey (BRASS)
James Galloway and others
Rheumatology, Volume 58, Issue Supplement_3, April 2019, kez106.074, https://doi.org/10.1093/rheumatology/kez106.074
Published: 12 April 2019
Journal Article
074 Summary of indirect comparison to evaluate efficacy of baricitinib with targeted synthetic and biologic disease anti-rheumatic drugs in patients with rheumatoid arthritis
Paul Emery and others
Rheumatology, Volume 58, Issue Supplement_3, April 2019, kez106.073, https://doi.org/10.1093/rheumatology/kez106.073
Published: 12 April 2019
Journal Article
076 Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors
Peter C Taylor and others
Rheumatology, Volume 58, Issue Supplement_3, April 2019, kez106.075, https://doi.org/10.1093/rheumatology/kez106.075
Published: 12 April 2019
Journal Article
226 Summary of baricitinib effect on patient-reported outcomes (PROs) in methotrexate-inadequate responder patient population
Get access
Maxime Dougados and others
Rheumatology, Volume 57, Issue suppl_3, April 2018, key075.450, https://doi.org/10.1093/rheumatology/key075.450
Published: 25 April 2018
Journal Article
233 Durability, maintenance and effects of dose reduction following prolonged treatment with baricitinib
Get access
Josef S Smolen and others
Rheumatology, Volume 57, Issue suppl_3, April 2018, key075.457, https://doi.org/10.1093/rheumatology/key075.457
Published: 25 April 2018
Journal Article
Nicotine-patch therapy on mucocutaneous lesions of Behçet’s disease: a case series
Get access
Giovanni Ciancio and others
Rheumatology, Volume 49, Issue 3, March 2010, Pages 501–504, https://doi.org/10.1093/rheumatology/kep401
Published: 16 December 2009
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals